| scholarly article | Q13442814 |
| P356 | DOI | 10.1001/ARCHPSYC.1996.01830030054009 |
| P698 | PubMed publication ID | 8611060 |
| P50 | author | Edward V. Nunes Jr. | Q90035477 |
| Frederic M. Quitkin | Q109460058 | ||
| P2093 | author name string | J W Stewart | |
| D Goldman | |||
| V Agosti | |||
| P J McGrath | |||
| K Ocepek-Welikson | |||
| P433 | issue | 3 | |
| P921 | main subject | placebo | Q269829 |
| P1104 | number of pages | 9 | |
| P304 | page(s) | 232-240 | |
| P577 | publication date | 1996-03-01 | |
| P1433 | published in | JAMA Psychiatry | Q635830 |
| P1476 | title | Imipramine treatment of alcoholics with primary depression: A placebo-controlled clinical trial | |
| P478 | volume | 53 |
| Q37224425 | A randomized, controlled, pilot study of acamprosate added to escitalopram in adults with major depressive disorder and alcohol use disorder |
| Q44335284 | Alcohol dependence and mood disorders |
| Q35421172 | Alcohol induced depressive-like behavior is associated with a reduction in hippocampal BDNF. |
| Q33965699 | Alcoholism treatment in the United States. An overview. |
| Q24234481 | Antidepressants for the treatment of depression in alcohol dependent individuals |
| Q53281420 | Antidepressants for the treatment of people with co-occurring depression and alcohol dependence. |
| Q35603615 | Co-occurring psychiatric disorders in women with addictions |
| Q35827977 | Cognitive-behavioral treatment for depression in alcoholism |
| Q34786788 | Comorbid psychiatric disorders in late life depression |
| Q22306294 | Comparison of induced and independent major depressive disorders in 2,945 alcoholics |
| Q34234906 | Consumers of mental health services |
| Q34123886 | Current concepts in the treatment of depression in alcohol-dependent patients |
| Q91600246 | Depression and Bipolar Disorders in Patients With Alcohol Use Disorders |
| Q48084457 | Depression and alcohol withdrawal syndrome: is antidepressant therapy associated with lower rates of hospital readmission? |
| Q35934883 | Double-blind, 12 month follow-up, placebo-controlled trial of mifepristone on cognition in alcoholics: the MIFCOG trial protocol |
| Q46712883 | Effectiveness and tolerability of mirtazapine and amitriptyline in alcoholic patients with co-morbid depressive disorder: a randomized, double-blind study |
| Q45216936 | Evidence-based pharmacotherapy for mood and anxiety disorders with concurrent alcoholism. |
| Q38664894 | Exercise training - A beneficial intervention in the treatment of alcohol use disorders? |
| Q44349217 | Fluoxetine treatment of depressive disorders in methadone-maintained opioid addicts |
| Q33938089 | Impact of substance abuse on the course and treatment of bipolar disorder |
| Q30400782 | Management of "dual diagnosis" patients : consensus, controversies and considerations |
| Q51093799 | Managing anxiety and depression in alcohol and drug dependence. |
| Q33534318 | Medications for alcohol, illicit drug, and tobacco dependence. An update of research findings |
| Q35070597 | Meta-analysis of supplemental treatment for depressive and anxiety disorders in patients being treated for alcohol dependence |
| Q30936896 | Pharmacotherapy of alcohol dependence: a review of the clinical data |
| Q36530191 | Pharmacotherapy of alcoholism in patients with co-morbid psychiatric disorders |
| Q33828162 | Placebo group improvement in trials of pharmacotherapies for alcohol use disorders: a multivariate meta-analysis examining change over time. |
| Q77461819 | Placebo-controlled study of sertraline in depressed recently abstinent alcoholics |
| Q36393188 | Prescription for antidepressant in reducing future alcohol-related readmission in patients suffering from depression and alcohol use disorder: a retrospective medical record review |
| Q94405654 | Prevalence and Co-Occurrence of Substance Use Disorders and Independent Mood and Anxiety Disorders: Results From the National Epidemiologic Survey on Alcohol and Related Conditions |
| Q33933287 | Psychopathology of alcoholics during withdrawal and early abstinence |
| Q87473058 | Psychopharmacology of substance misuse and comorbid psychiatric disorders |
| Q43070608 | Recommended drug treatment strategies for the alcoholic patient |
| Q38926517 | Relapse Prevention in Alcoholism : Recent Advances and Future Possibilities |
| Q30435306 | Role of the serotonergic system in the neurobiology of alcoholism: implications for treatment |
| Q44829771 | Screening for psychiatric disorders in outpatients with DSM-IV substance use disorders |
| Q44659872 | Sertraline and Cognitive Behavioral Therapy for Depressed Alcoholics: Results of A Placebo-Controlled Trial |
| Q47642128 | The Black Book of Psychotropic Dosing and Monitoring |
| Q44689212 | The comorbidity of alcohol dependence and affective disorders: treatment implications |
| Q41127953 | The management of treatment resistance in depressed patients with substance use disorders |
| Q36591824 | Treating depression in substance abusers |
| Q37625018 | Treating nicotine dependence by targeting attention-deficit/ hyperactivity disorder (ADHD) with OROS methylphenidate: the role of baseline ADHD severity and treatment response. |
| Q30443221 | Treating smoking dependence in depressed alcoholics |
| Q92898347 | Treatment for Substance Use Disorder With Co-Occurring Mental Illness |
| Q44628811 | Treatment of Alcohol Abuse: An Evidence‐Based Review |
| Q37292488 | Treatment of Co-occurring Depression and Substance Dependence: Using Meta-analysis to Guide Clinical Recommendations |
| Q35212161 | Treatment of late-life depression complicated by alcohol dependence |
| Q30440516 | Update on neuropharmacological treatments for alcoholism: scientific basis and clinical findings |
| Q37446677 | Using patient self-reports to study heterogeneity of treatment effects in major depressive disorder |
| Q28373224 | Venlafaxine treatment of cocaine abusers with depressive disorders |
Search more.